Literature DB >> 2024059

[Intracavitary treatment of malignant pleural effusion with iodine-povidone].

A Echavarría1, V Pinzón, J P Barés, E Fernández.   

Abstract

The authors present 15 patients with proven malignant pleural effusion who underwent pleurodesis with Povidone. They obtained a complete response in 100% of the cases. The average duration of the response was 23.3 weeks ranging from 3 to 83 weeks. Seven patients are alive and on follow up with an average response time of 30 weeks. Six patients are dead, with an average response time of fifteen weeks. We don't know the late results in 2 patients after the control (4 weeks after treatment). The pleural tube remained in place from 2 to 8 days. There were no untoward or colateral effects in these patients. The cost of the Povidone utilized was B/0.40 per patient. The cost, the efficacy and the absence of ill effects make Povidone the agent of choice in the palliative treatment of malignant pleural effusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024059

Source DB:  PubMed          Journal:  Rev Med Panama        ISSN: 0379-1629


  6 in total

1.  Iodopovidone pleurodesis for malignant pleural effusions: an updated systematic review and meta-analysis.

Authors:  Valliappan Muthu; Sahajal Dhooria; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Ashutosh N Aggarwal; Ritesh Agarwal
Journal:  Support Care Cancer       Date:  2021-01-30       Impact factor: 3.603

2.  An observational study on safety and efficacy of povidone-iodine for pleurodesis in cancer patients.

Authors:  Ayush Makkar; Sanjeev Patni; Anjum Khan Joad; Kamal Kishor Lakhera
Journal:  South Asian J Cancer       Date:  2017 Apr-Jun

3.  Video-assisted thoracoscopic iodopovidone pleurodesis for malignant pleural effusions in moderate to high-risk Colombian patients.

Authors:  Juan Carlos Garzón; Eric Edward Vinck; Diana Carolina Cárdenas; Luis Jaime Téllez
Journal:  J Cardiovasc Thorac Res       Date:  2020-12-01

4.  The comparison of pleurodesis effects of iodopovidone at different concentrations and magnesium silicate: An experimental study.

Authors:  Ekin Zorlu; Salih Kür; Zeynep Pekcan; Pınar Atasoy; Nesimi Günal; Koray Dural; Berkant Özpolat
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-10-20       Impact factor: 0.332

Review 5.  Efficacy & safety of iodopovidone pleurodesis: a systematic review & meta-analysis.

Authors:  Ritesh Agarwal; Ajmal Khan; Ashutosh N Aggarwal; Dheeraj Gupta
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

6.  Effectiveness and safety of iodopovidone in an experimental pleurodesis model.

Authors:  Lisete R Teixeira; Francisco S Vargas; Juliana Puka; Milena M P Acencio; Leila Antonangelo; Ricardo M Terra; Francisco M Damico; Fabio G Pitta; Evaldo Marchi
Journal:  Clinics (Sao Paulo)       Date:  2013-04       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.